Wexford Capital’s Labcorp LH Stock Holding History

Wexford Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-5,052	Closed	-$508K	–	125
2016 Q1	$508K	Buy	+5,052	New	+$484K	0.1%	88

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Wexford Capital's LH Position: Q2 2016 in Review

Wexford Capital sold out of Labcorp (LH) in Q2 2016, closing a stake of 5,052 shares — an estimated $508K sold.

Wexford Capital first reported a position in LH in Q1 2016 and held it in 1 quarter. The position peaked at $508K in Q1 2016. 687 funds tracked by Wall St. Rank hold LH as of Q2 2016.

Wexford Capital reported no remaining Labcorp position as of Q2 2016 after selling out during the quarter.
Wexford Capital sold 5,052 Labcorp shares in Q2 2016, an estimated $508K.
Wexford Capital first reported a position in Labcorp in Q1 2016 and held it in 1 quarter.
Wexford Capital's Labcorp position peaked at $508K in Q1 2016.
687 funds tracked by Wall St. Rank held Labcorp as of Q2 2016.

Based on Wexford Capital's 13F filing for Q2 2016, filed 12 Aug 2016.